Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS Cameroon hepatitis C test-and-treat strategy trial
PACTR202507792256411Phase 4Not yet recruiting
- Sponsor
- ANRS
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sofosbuvir in hepatitis C virus infection, sponsored by ANRS. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on PACTR202507792256411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507792256411.